[go: up one dir, main page]

WO2004007764A3 - Genes des chromosomes 3,5 et 11 impliques dans la canitie precoce - Google Patents

Genes des chromosomes 3,5 et 11 impliques dans la canitie precoce Download PDF

Info

Publication number
WO2004007764A3
WO2004007764A3 PCT/FR2003/002153 FR0302153W WO2004007764A3 WO 2004007764 A3 WO2004007764 A3 WO 2004007764A3 FR 0302153 W FR0302153 W FR 0302153W WO 2004007764 A3 WO2004007764 A3 WO 2004007764A3
Authority
WO
WIPO (PCT)
Prior art keywords
whereof
human chromosome
gene selected
sequence corresponds
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2003/002153
Other languages
English (en)
Other versions
WO2004007764A2 (fr
Inventor
Lacharriere Olivier De
Jean-Louis Blouin
Claire Deloche
Stylianos Antonarakis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to BR0305436-5A priority Critical patent/BR0305436A/pt
Priority to AU2003267513A priority patent/AU2003267513A1/en
Priority to JP2004520753A priority patent/JP2005532407A/ja
Priority to CA002491235A priority patent/CA2491235A1/fr
Priority to EP03748204A priority patent/EP1520042A2/fr
Publication of WO2004007764A2 publication Critical patent/WO2004007764A2/fr
Publication of WO2004007764A3 publication Critical patent/WO2004007764A3/fr
Priority to US11/031,033 priority patent/US20050208010A1/en
Anticipated expiration legal-status Critical
Priority to US11/583,512 priority patent/US20070065389A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A61Q5/065—Preparations for temporary colouring the hair, e.g. direct dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/148—Screening for cosmetic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Birds (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Utilisation d'au moins un fragment polynucléotidique comprenant au moins 18 nucléotides consécutifs dont la séquence correspond à tout ou partie d'un gène du chromosome 3 humain choisi parmi les gènes KIAA1042, CCK, CACNAID, ARHGEF3 et AL133097, ou dont la séquence correspond à tout ou partie d'un gène du chromosome 5 humain choisi parmi les gènes KLHL3, HNRPAO, CDC25C, EGR1, C5orf6, C5orf7, LOC51308, ETF1, HSPA9B, PCDHAI à PCDHA13, CSF1R, RPL7, PDGFRB, TCOF1, AL133039, CD74, RPS14, NDST1, G3BP, GLRA1, C5orf3, MFAP3, GALNTIO et FLJ11715, ou dont la séquence correspond à tout ou partie d'un gène du chromosome 11 humain choisi parmi les gènes GUCYIA2, CULS, ACAT1, NPAT, ATM, AF035326, AF035327, AF035328, BC029536, FLJ20535, DRD2, ENS303941, IGSF4, LOC51092, BC010946, TAGLN, PCSK7 et ENS300650, utilisation d'agents capables de modifier la fonction attachée à l'une de ces régions, utilisation des produits d'expression de l'une de ces régions et utilisation d'agents capables de modifier la fonction de ces produits d'expression, à des fins cosmétiques, thérapeutiques ou diagnostiques.
PCT/FR2003/002153 2002-07-10 2003-07-09 Genes des chromosomes 3,5 et 11 impliques dans la canitie precoce Ceased WO2004007764A2 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
BR0305436-5A BR0305436A (pt) 2002-07-10 2003-07-09 Utilização de pelo menos um fragmento polinucleotìdico e de uma combinação de pelo menos dois fragmentos poliniucleotìdicos, processo para o diagnóstico de uma predisposição a encanecimento precoce em um indivìduo, e, kit
AU2003267513A AU2003267513A1 (en) 2002-07-10 2003-07-09 Chromosome 3, 5 and 11 genes involved in premature canities
JP2004520753A JP2005532407A (ja) 2002-07-10 2003-07-09 若白髪に関与する染色体３、５、１１の遺伝子
CA002491235A CA2491235A1 (fr) 2002-07-10 2003-07-09 Genes des chromosomes 3,5 et 11 impliques dans la canitie precoce
EP03748204A EP1520042A2 (fr) 2002-07-10 2003-07-09 Genes des chromosomes 3,5 et 11 impliques dans la canitie precoce
US11/031,033 US20050208010A1 (en) 2002-07-10 2005-01-10 Genes from Chromosome 3, 5 and 11 involved in premature canities
US11/583,512 US20070065389A1 (en) 2002-07-10 2006-10-18 Genes from chromosomes 3, 5 and 11 involved in premature canities

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR02/08697 2002-07-10
FR0208697A FR2842105B1 (fr) 2002-07-10 2002-07-10 Localisation des genes impliques dans la canitie precoce

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/031,033 Continuation US20050208010A1 (en) 2002-07-10 2005-01-10 Genes from Chromosome 3, 5 and 11 involved in premature canities

Publications (2)

Publication Number Publication Date
WO2004007764A2 WO2004007764A2 (fr) 2004-01-22
WO2004007764A3 true WO2004007764A3 (fr) 2004-04-08

Family

ID=29763718

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2003/002153 Ceased WO2004007764A2 (fr) 2002-07-10 2003-07-09 Genes des chromosomes 3,5 et 11 impliques dans la canitie precoce

Country Status (7)

Country Link
EP (1) EP1520042A2 (fr)
JP (1) JP2005532407A (fr)
AU (1) AU2003267513A1 (fr)
BR (1) BR0305436A (fr)
CA (1) CA2491235A1 (fr)
FR (1) FR2842105B1 (fr)
WO (1) WO2004007764A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2864899A1 (fr) * 2004-01-08 2005-07-15 Oreal Differents genes impliques dans la canitie precoce
WO2005068650A2 (fr) * 2004-01-08 2005-07-28 L'oreal Divers genes impliques dans des canities precoces
JP5384357B2 (ja) 2006-11-06 2014-01-08 クゥアルコム・インコーポレイテッド Ｐａｒ考察を備えたｕｌｍｉｍｏ／ｓｉｍｏ動作のための電力割り当ておよび／またはレート選択のための方法および装置
FR2930775B1 (fr) 2008-04-30 2010-05-21 Oreal Utilisations de bnipxl-beta dans la canitie precoce
JP5695383B2 (ja) 2009-10-05 2015-04-01 花王株式会社 毛髪形状感受性遺伝子
JP5695384B2 (ja) 2009-10-05 2015-04-01 花王株式会社 毛髪形状感受性遺伝子
JP5695385B2 (ja) 2009-10-05 2015-04-01 花王株式会社 毛髪形状感受性遺伝子

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001773A1 (fr) * 1993-07-07 1995-01-19 Trustees Of Boston University Stimulation du bronzage par des fragments d'adn
WO1996036691A1 (fr) * 1995-05-16 1996-11-21 Ramot-Univ. Authority For Applied Research And Industrial Development Ltd. Gene de l'ataxia-telangiectasie et son organisation genomique
WO2000047770A1 (fr) * 1999-02-15 2000-08-17 Catalyst Biomedica Ltd. Locus de susceptibilite de l'osteoarthrite

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001773A1 (fr) * 1993-07-07 1995-01-19 Trustees Of Boston University Stimulation du bronzage par des fragments d'adn
WO1996036691A1 (fr) * 1995-05-16 1996-11-21 Ramot-Univ. Authority For Applied Research And Industrial Development Ltd. Gene de l'ataxia-telangiectasie et son organisation genomique
WO2000047770A1 (fr) * 1999-02-15 2000-08-17 Catalyst Biomedica Ltd. Locus de susceptibilite de l'osteoarthrite

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BARSH G S: "The genetics of pigmentation: from fancy genes to complex traits", TRENDS IN GENETICS, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, vol. 12, no. 8, 1 August 1996 (1996-08-01), pages 299 - 305, XP004037138, ISSN: 0168-9525 *
HEMMINKI A ET AL: "Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis", NATURE GENETICS, NEW YORK, NY, US, vol. 15, no. 1, 15 January 1997 (1997-01-15), pages 87 - 90, XP001105579, ISSN: 1061-4036 *
OETTING W S ET AL: "Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism.", HUMAN MUTATION. UNITED STATES 1999, vol. 13, no. 2, 1999, pages 99 - 115, XP008018509, ISSN: 1059-7794 *
TASSABEHJI M ET AL: "Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene", NATURE GENETICS, NEW YORK, NY, US, vol. 8, no. 3, November 1994 (1994-11-01), pages 251 - 255, XP000909097, ISSN: 1061-4036 *

Also Published As

Publication number Publication date
AU2003267513A1 (en) 2004-02-02
CA2491235A1 (fr) 2004-01-22
FR2842105B1 (fr) 2012-12-28
WO2004007764A2 (fr) 2004-01-22
BR0305436A (pt) 2004-09-28
EP1520042A2 (fr) 2005-04-06
FR2842105A1 (fr) 2004-01-16
JP2005532407A (ja) 2005-10-27
AU2003267513A8 (en) 2004-02-02

Similar Documents

Publication Publication Date Title
EP1255827B8 (fr) Oligonucleotides et leur utilisation pour moduler l'expression de la tyrosinase intervenant dans la synthese de pigments melaniques
ATE249810T1 (de) Eisenoxidnanopigmente enthaltende zusammensetzungen für die künstliche bräunung der haut und andere verwendungen
MXPA04000179A (es) Oligonucleotidos sinteticos de hebra doble para inhibicion especifica de expresion de gene.
AU3601900A (en) Compositions comprising nickel and their use as catalyst in oxidative dehydrogenation of alkanes
WO2002055034A3 (fr) Compositions cosmetiques contenant un fructane, un polysaccharide et un agent benefique et leurs utilisations
WO2005018558A3 (fr) Article autogonflable
DE69516166D1 (de) Selbstmordgene und hybride aus nukleotid oder pyrimidin-nukleosid-analogen mit selbstmordgene für die gentherapie
BR0304289A (pt) Composições e artigos depilatórios e uso dos mesmos
WO2004007764A3 (fr) Genes des chromosomes 3,5 et 11 impliques dans la canitie precoce
BRPI0506907A (pt) agente para tratamento oxidante, particularmente em forma de gel transparente
WO1996021424A3 (fr) Concentres froids, doux, creant un effet irise
DE69525736D1 (de) Oligonukleotid und kanzerostatisches mittel das dieses als aktiven inhaltstoff enthält
WO1996021711A3 (fr) Concentres nacres prepares a froid
AU2001240940A1 (en) Cosmetic and dermatological composition for psoriatic skin, scalp treatment and care
WO2010047993A3 (fr) Copolymères de polyéther-silicone à fonctions amino terminales bloquées utiles dans des compositions de soins personnels
DE60037826D1 (de) Gene von felincalizivirus und impstoffe, die diese gene enthalten
WO2003101376A3 (fr) Utilisation par voie topique d'au moins un oligonucleotide d'arn double brin (ds rna)
EP1507790A4 (fr) Genes humains et produits d'expression geniques isoles d'une prostate humaine
NO20004309L (no) HÕrmiddel
WO2003066007A8 (fr) Compositions de soin capillaire contenant des polysiloxanes
WO2001034819A3 (fr) Genes et methodes de manipulation de croissance
HRP20100666T1 (hr) ANTI MIOZINSKA Va siRNA I DEPIGMENTACIJA KOŽE
FR2819404B1 (fr) Compositions cosmetiques contenant un fructane et un polymere cationique et leurs utilisations
ATE295367T1 (de) Doppelsträngiges oligonukleotid und karzinostatisches mittel das dieses als aktiven inhaltsstoff enthält
WO2004007742A3 (fr) Genes des chromosomes 6 et 9 impliques dans la canitie precoce

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2491235

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 11031033

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2004520753

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003748204

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003748204

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2003748204

Country of ref document: EP